Cannon M E, Carpenter S L, Elta G H, Nostrant T T, Kochman M L, Ginsberg G G, Stotland B, Rosato E F, Morris J B, Eckhauser F, Scheiman J M
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA.
Gastrointest Endosc. 1999 Jul;50(1):27-33. doi: 10.1016/s0016-5107(99)70340-8.
Computerized tomography (CT), magnetic resonance imaging (MRI), and transabdominal ultrasound frequently fail to detect ampullary lesions. Endoscopic ultrasound (EUS) is a sensitive modality for detecting and staging ampullary tumors. Accurate staging may be affected by biliary stenting, which is frequently performed in these patients with obstructive jaundice. The present study assessed the accuracy of ampullary tumor staging with multiple imaging modalities in patients with and those without endobiliary stents.
Fifty consecutive patients with ampullary neoplasms from two endosonography centers were preoperatively staged by EUS plus CT (37 patients), MRI (13 patients), or angiography (10 patients) over a 3(1/2) year period. Twenty-five of the 50 patients had a transpapillary endobiliary stent present at the time of endosonographic examination. Accuracy of EUS, CT, MRI, and angiography was assessed with the TNM classification system and compared with surgical-pathologic staging. The influence of an endobiliary stent present at the time of EUS on staging accuracy of EUS was also evaluated.
EUS was more accurate than CT and MRI in the overall assessment of the T stage of ampullary neoplasms (EUS 78%, CT 24%, MRI 46%). No significant difference in N stage accuracy was noted between the three imaging modalities (EUS 68%, CT 59%, MRI 77%). EUS T stage accuracy was reduced from 84% to 72% in the presence of a transpapillary endobiliary stent. This was most prominent in the understaging of T2/T3 carcinomas.
EUS is superior to CT and MRI in assessing T stage but not N stage of ampullary lesions. The presence of an endobiliary stent at EUS may result in underestimating the need for a Whipple resection because of tumor understaging.
计算机断层扫描(CT)、磁共振成像(MRI)和经腹超声常常无法检测出壶腹病变。内镜超声(EUS)是检测壶腹肿瘤及其分期的一种敏感方法。准确分期可能会受到胆道支架置入术的影响,而在这些梗阻性黄疸患者中,胆道支架置入术经常施行。本研究评估了有或没有胆道内支架的患者使用多种成像方式对壶腹肿瘤进行分期的准确性。
在3年半的时间里,来自两个超声内镜检查中心的50例连续壶腹肿瘤患者术前通过EUS联合CT(37例患者)、MRI(13例患者)或血管造影(10例患者)进行分期。50例患者中有25例在超声内镜检查时存在经乳头胆道支架。采用TNM分类系统评估EUS、CT、MRI和血管造影的准确性,并与手术病理分期进行比较。还评估了超声内镜检查时存在的胆道支架对超声内镜分期准确性的影响。
在壶腹肿瘤T分期的总体评估中,EUS比CT和MRI更准确(EUS为78%,CT为24%,MRI为46%)。三种成像方式在N分期准确性方面未发现显著差异(EUS为68%,CT为59%,MRI为77%)。在存在经乳头胆道支架的情况下,EUS T分期准确性从84%降至72%。这在T2/T3期癌的分期过低中最为明显。
在评估壶腹病变的T分期方面,EUS优于CT和MRI,但在N分期方面并非如此。超声内镜检查时存在胆道支架可能会因肿瘤分期过低而导致低估Whipple手术的必要性。